cefoperazone has been researched along with Disease Resistance in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beger, RD; Carlson, PE; Cowley, SC; Foss, ED; Gasparyan, L; Giordano, NP; Hastie, JL; McMichael, HL; Prasad, D; Schubert, AM; Simonyan, V; Smith, AD; Sun, J; VinhNguyen, LP; Zhang, I | 1 |
1 other study(ies) available for cefoperazone and Disease Resistance
Article | Year |
---|---|
Microbiota of MR1 deficient mice confer resistance against Clostridium difficile infection.
Topics: Animals; Anti-Bacterial Agents; Cefoperazone; Clostridium Infections; Disease Models, Animal; Disease Resistance; Fecal Microbiota Transplantation; Feces; Gastrointestinal Microbiome; Histocompatibility Antigens Class I; Humans; Intestinal Mucosa; Mice; Mice, Knockout; Minor Histocompatibility Antigens; Mucosal-Associated Invariant T Cells; Specific Pathogen-Free Organisms | 2019 |